Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Archives of Gynecology and Obstetrics
Erschienen in: Archives of Gynecology and Obstetrics 2/2017

05.06.2017 | Review

The role of prostaglandins E1 and E2, dinoprostone, and misoprostol in cervical ripening and the induction of labor: a mechanistic approach

verfasst von: Ronan Bakker, Stephanie Pierce, Dean Myers

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Prostaglandins play a critical role in cervical ripening by increasing inflammatory mediators in the cervix and inducing cervical remodeling. Prostaglandin E1 (PGE1) and prostaglandin E2 (PGE2) exert different effects on these processes and on myometrial contractility. These mechanistic differences may affect outcomes in women treated with dinoprostone, a formulation identical to endogenous PGE2, compared with misoprostol, a PGE1 analog. The objective of this review is to evaluate existing evidence regarding mechanistic differences between PGE1 and PGE2, and consider the clinical implications of these differences in patients requiring cervical ripening for labor induction.

Methods

We conducted a critical narrative review of peer-reviewed articles identified using PubMed and other online databases.

Results

While both dinoprostone and misoprostol are effective in cervical ripening and labor induction, they differ in their clinical and pharmacological profiles. PGE2 has been shown to stimulate interleukin-8, an inflammatory cytokine that promotes the influx of neutrophils and induces remodeling of the cervical extracellular matrix, and to induce functional progesterone withdrawal. Misoprostol has been shown to elicit a dose-dependent effect on myometrial contractility, which may affect rates of uterine tachysystole in clinical practice.

Conclusions

Differences in the mechanism of action between misoprostol and PGE2 may contribute to their variable effects in the cervix and myometrium, and should be considered to optimize outcomes.
Literatur
1.
World Health Organization (2011) WHO recommendations for induction of labour. WHO, Geneva
2.
Osterman MJ, Martin JA (2014) Recent declines in induction of labor by gestational age. NCHS Data Brief 155:1–8
3.
Hamilton BE, Martin JA, Osterman MJ, Curtin SC, Matthews TJ (2015) Births: final data for 2014. Natl Vital Stat Rep 64(12):1–64
4.
Teixeira C, Lunet N, Rodrigues T, Barros H (2012) The Bishop Score as a determinant of labour induction success: a systematic review and meta-analysis. Arch Gynecol Obstet 286(3):739–753PubMedCrossRef
5.
Word RA, Li XH, Hnat M, Carrick K (2007) Dynamics of cervical remodeling during pregnancy and parturition: mechanisms and current concepts. Semin Reprod Med 25(1):69–79PubMedCrossRef
6.
Denison FC, Calder AA, Kelly RW (1999) The action of prostaglandin E2 on the human cervix: stimulation of interleukin 8 and inhibition of secretory leukocyte protease inhibitor. Am J Obstet Gynecol 180(3 Pt 1):614–620PubMedCrossRef
7.
Konopka CK, Glanzner WG, Rigo ML, Rovani MT, Comim FV, Goncalves PB, Morais EN, Antoniazzi AQ, Mello CF, Cruz IB (2015) Responsivity to PGE2 labor induction involves concomitant differential prostaglandin E receptor gene expression in cervix and myometrium. Genet Mol Res 14(3):10877–10887PubMedCrossRef
8.
Cowan S, Calder AA (2004) Parturition and the clinical interruption of pregnancy. In: Curtis-Prior P (ed) The eicosanoids. Wiley, Chichester
9.
Terzidou V (2007) Preterm labour. Biochemical and endocrinological preparation for parturition. Best Pract Res Clin Obstet Gynaecol 21(5):729–756PubMedCrossRef
10.
11.
Breyer MD, Hebert RL, Breyer RM (2003) Prostanoid receptors and the urogenital tract. Curr Opin Investig Drugs 4(11):1343–1353PubMed
12.
Astle S, Thornton S, Slater DM (2005) Identification and localization of prostaglandin E2 receptors in upper and lower segment human myometrium during pregnancy. Mol Hum Reprod 11(4):279–287PubMedCrossRef
13.
Grigsby PL, Sooranna SR, Brockman DE, Johnson MR, Myatt L (2006) Localization and expression of prostaglandin E2 receptors in human placenta and corresponding fetal membranes with labor. Am J Obstet Gynecol 195(1):260–269PubMedCrossRef
14.
Unlugedik E, Alfaidy N, Holloway A, Lye S, Bocking A, Challis J, Gibb W (2010) Expression and regulation of prostaglandin receptors in the human placenta and fetal membranes at term and preterm. Reprod Fertil Dev 22(5):796–807PubMedCrossRef
15.
Smith GC, Baguma-Nibasheka M, Wu WX, Nathanielsz PW (1998) Regional variations in contractile responses to prostaglandins and prostanoid receptor messenger ribonucleic acid in pregnant baboon uterus. Am J Obstet Gynecol 179(6 Pt 1):1545–1552PubMedCrossRef
16.
Smith GC, Wu WX, Nathanielsz PW (2001) Expression of prostanoid receptor genes in baboon chorion and decidua during pregnancy and parturition. J Endocrinol 168(2):263–272PubMedCrossRef
17.
Collins PW (1990) Misoprostol: discovery, development, and clinical applications. Med Res Rev 10(2):149–172PubMedCrossRef
18.
Kurzrok R, Lieb CC (1930) Biochemical studies of human semen. II. The action of semen on the human uterus. Proc Soc Exp Biol Med 28(3):268–272CrossRef
19.
von Euler US (1936) On the specific vaso-dilating and plain muscle stimulating substances from accessory genital glands in man and certain animals (prostaglandin and vesiglandin). J Physiol 88(2):213–234CrossRef
20.
Tattersall M, Engineer N, Khanjani S, Sooranna SR, Roberts VH, Grigsby PL, Liang Z, Myatt L, Johnson MR (2008) Pro-labour myometrial gene expression: are preterm labour and term labour the same? Reproduction 135(4):569–579PubMedCrossRef
21.
Vannuccini S, Bocchi C, Severi FM, Challis JR, Petraglia F (2016) Endocrinology of human parturition. Ann Endocrinol 77(2):105–113CrossRef
22.
Reece MS, McGregor JA, Allen KG, Mathias MM, Harris MA (1996) Prostaglandins in selected reproductive tissues in preterm and full-term gestations. Prostaglandins Leukot Essent Fatty Acids 55(5):303–307PubMedCrossRef
23.
Olson DM, Ammann C (2007) Role of the prostaglandins in labour and prostaglandin receptor inhibitors in the prevention of preterm labour. Front Biosci 12:1329–1343PubMedCrossRef
24.
Blesson CS, Sahlin L (2014) Prostaglandin E and F receptors in the uterus. Recept Clin Investig 1:e115
25.
Kershaw-Young CM, Scaramuzzi RJ, McGowan MR, Pitsillides AA, Wheeler-Jones CP, Khalid M (2010) The effect of estradiol on COX-2, EP2, and EP4 mRNA expression and the extracellular matrix in the cervix of the hypogonadotrophic, ovariectomized ewe. Theriogenology 73(5):620–628PubMedCrossRef
26.
El Maradny E, Kanayama N, Kobayashi H, Hossain B, Khatun S, Liping S, Kobayashi T, Terao T (1997) The role of hyaluronic acid as a mediator and regulator of cervical ripening. Hum Reprod 12(5):1080–1088PubMedCrossRef
27.
Osmers R, Rath W, Adelmann-Grill BC, Fittkow C, Szeverenyi M, Kuhn W (1991) Collagenase activity in the human cervix uteri after prostaglandin E2 application during the first trimester. Eur J Obstet Gynecol Reprod Biol 42(1):29–32PubMedCrossRef
28.
Ravanos K, Dagklis T, Petousis S, Margioula-Siarkou C, Prapas Y, Prapas N (2015) Factors implicated in the initiation of human parturition in term and preterm labor: a review. Gynecol Endocrinol 31(9):679–683PubMedCrossRef
29.
Aronsson A, Ulfgren AK, Stabi B, Stavreus-Evers A, Gemzell-Danielsson K (2005) The effect of orally and vaginally administered misoprostol on inflammatory mediators and cervical ripening during early pregnancy. Contraception 72(1):33–39PubMedCrossRef
30.
Li XH, Kishore AH, Dao D, Zheng W, Roman CA, Word RA (2010) A novel isoform of microphthalmia-associated transcription factor inhibits IL-8 gene expression in human cervical stromal cells. Mol Endocrinol 24(8):1512–1528PubMedPubMedCentralCrossRef
31.
Pharmaceuticals Ferring (2016) Cervidil® [prescribing information]. Ferring Pharmaceuticals Inc., Parsippany
32.
Robert A, Nezamis JE, Phillips JP (1967) Inhibition of gastric secretion by prostaglandins. Am J Dig Dis 12(10):1073–1076PubMedCrossRef
33.
Tang OS, Gemzell-Danielsson K, Ho PC (2007) Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet 99(Suppl 2):S160–S167PubMedCrossRef
34.
Danielsson KG, Marions L, Rodriguez A, Spur BW, Wong PY, Bygdeman M (1999) Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol 93(2):275–280PubMed
35.
36.
Sugimoto Y, Inazumi T, Tsuchiya S (2015) Roles of prostaglandin receptors in female reproduction. J Biochem 157(2):73–80PubMedCrossRef
37.
Blanks AM, Shmygol A, Thornton S (2007) Preterm labour. Myometrial function in prematurity. Best Pract Res Clin Obstet Gynaecol 21(5):807–819PubMedCrossRef
38.
Khan AH, Carson RJ, Nelson SM (2008) Prostaglandins in labor—a translational approach. Front Biosci 13:5794–5809PubMedCrossRef
39.
Palliser HK, Hirst JJ, Ooi GT, Rice GE, Dellios NL, Escalona RM, Parkington HC, Young IR (2005) Prostaglandin E and F receptor expression and myometrial sensitivity at labor onset in the sheep. Biol Reprod 72(4):937–943PubMedCrossRef
40.
Coleman RA, Smith WL, Narumiya S (1994) International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46(2):205–229PubMed
41.
Narumiya S, Sugimoto Y, Ushikubi F (1999) Prostanoid receptors: structures, properties, and functions. Physiol Rev 79(4):1193–1226PubMed
42.
Terry KK, Lebel WS, Riccardi KA, Grasser WA, Thompson DD, Paralkar VM (2008) Effects of gestational age on prostaglandin EP receptor expression and functional involvement during in vitro contraction of the guinea pig uterus. Prostaglandins Leukot Essent Fatty Acids 78(1):3–10PubMedCrossRef
43.
Nathanielsz PW, Smith G, Wu W (2004) Topographical specialization of prostaglandin function in late pregnancy and at parturition in the baboon. Prostaglandins Leukot Essent Fatty Acids 70(2):199–206PubMedCrossRef
44.
Brodt-Eppley J, Myatt L (1999) Prostaglandin receptors in lower segment myometrium during gestation and labor. Obstet Gynecol 93(1):89–93PubMed
45.
Lyons C, Beharry K, Akmal Y, Attenello F, Nageotte MP (2003) In vitro response of prostaglandin E2 receptor (EP3) in the term pregnant rat uterus and cervix to misoprostol. Prostaglandins Other Lipid Mediat 70(3–4):317–329PubMedCrossRef
46.
Schmitz T, Leroy MJ, Dallot E, Breuiller-Fouche M, Ferre F, Cabrol D (2003) Interleukin-1β induces glycosaminoglycan synthesis via the prostaglandin E2 pathway in cultured human cervical fibroblasts. Mol Hum Reprod 9(1):1–8PubMedPubMedCentralCrossRef
47.
Brodt-Eppley J, Myatt L (1998) Changes in expression of contractile FP and relaxatory EP2 receptors in pregnant rat myometrium during late gestation, at labor, and postpartum. Biol Reprod 59(4):878–883PubMedCrossRef
48.
Ma X, Wu WX, Nathanielsz PW (1999) Differential regulation of prostaglandin EP and FP receptors in pregnant sheep myometrium and endometrium during spontaneous term labor. Biol Reprod 61(5):1281–1286PubMedCrossRef
49.
Smith GCS, Wu WX, Nathanielsz PW (2001) Effects of gestational age and labor on expression of prostanoid receptor genes in baboon uterus. Biol Reprod 64(4):1131–1137PubMedCrossRef
50.
Wing DA, Goharkhay N, Hanna M, Naidu YM, Kovacs BW, Felix JC (2003) EP3-2 receptor mRNA expression is reduced and EP3-6 receptor mRNA expression is increased in gravid human myometrium. J Soc Gynecol Investig 10(3):124–129PubMedCrossRef
51.
Woodward DF, Jones RL, Narumiya S (2011) International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress. Pharmacol Rev 63(3):471–538PubMedCrossRef
52.
Leonhardt A, Glaser A, Wegmann M, Hackenberg R, Nusing RM (2003) Expression of prostanoid receptors in human lower segment pregnant myometrium. Prostaglandins Leukot Essent Fatty Acids 69(5):307–313PubMedCrossRef
53.
Mosher AA, Rainey KJ, Giembycz MA, Wood S, Slater DM (2012) Prostaglandin E2 represses interleukin 1 beta-induced inflammatory mediator output from pregnant human myometrial cells through the EP2 and EP4 receptors. Biol Reprod 87(1):7, 1–10
54.
Hinton AC, Grigsby PL, Pitzer BA, Brockman DE, Ittenbach RF, Hinton RB, Myatt L (2010) Hormonal regulation of prostaglandin E2 receptors: localization and expression in rat cervical tissue. Reprod Sci 17(2):136–146PubMedCrossRef
55.
Chien EK, MacGregor C (2003) Expression and regulation of the rat prostaglandin E2 receptor type 4 (EP4) in pregnant cervical tissue. Am J Obstet Gynecol 189(5):1501–1510PubMedCrossRef
56.
Smith GC, Wu WX, Nathanielsz PW (2001) Effects of gestational age and labor on the expression of prostanoid receptor genes in pregnant baboon cervix. Prostaglandins Other Lipid Mediat 63(4):153–163PubMedCrossRef
57.
Blesson CS, Roos N, Stephansson O, Masironi B, Reinert S, Stjernholm YV, Ekman-Ordeberg G, Sahlin L (2013) Expression and localization of prostaglandin receptors and stromal factors in human cervix—variations in pregnant and non-pregnant states. Open J Mol Integr Physiol 3:147–157CrossRef
58.
Konopka CK, Morais EN, Naidon D, Pereira AM, Rubin MA, Oliveira JF, Mello CF (2013) Maternal serum progesterone, estradiol and estriol levels in successful dinoprostone-induced labor. Braz J Med Biol Res 46(1):91–97PubMedPubMedCentralCrossRef
59.
Grignaffini A, Soncini E, Anfuso S, Ronzoni E (2004) Dinoprostone: slow release vaginal insert (Propess) and intracervical gel (Prepidil) for the induction of labour with unriped cervix. Article in Italian. Minerva Ginecol 56(5):413–418PubMed
60.
Roos N, Blesson CS, Stephansson O, Masironi B, Vladic Stjernholm Y, Ekman-Ordeberg G, Sahlin L (2014) The expression of prostaglandin receptors EP3 and EP4 in human cervix in post-term pregnancy differs between failed and successful labor induction. Acta Obstet Gynecol Scand 93(2):159–167PubMedCrossRef
61.
Chillar AJ (2010) Binding and signaling differences between prostaglandin E1 and E2 mediated by prostaglandin E subtype receptors. Dissertation, Department of Pharmacological and Pharmaceutical Sciences, University of Houston
62.
Iyu D, Juttner M, Glenn JR, White AE, Johnson AJ, Fox SC, Heptinstall S (2011) PGE1 and PGE2 modify platelet function through different prostanoid receptors. Prostaglandins Other Lipid Mediat 94(1–2):9–16PubMedCrossRef
63.
Breyer RM, Bagdassarian CK, Myers SA, Breyer MD (2001) Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 41:661–690PubMedCrossRef
64.
Chiossi G, Costantine MM, Bytautiene E, Kechichian T, Hankins GD, Sbrana E, Saade GR, Longo M (2012) The effects of prostaglandin E1 and prostaglandin E2 on in vitro myometrial contractility and uterine structure. Am J Perinatol 29(8):615–622PubMedPubMedCentralCrossRef
65.
Ji H, Dailey TL, Long V, Chien EK (2008) Prostaglandin E2-regulated cervical ripening: analysis of proteoglycan expression in the rat cervix. Am J Obstet Gynecol 198(5):536–537PubMed
66.
Sahlin L, Stjernholm-Vladic Y, Roos N, Masironi B, Ekman-Ordeberg G (2008) Impaired leukocyte influx in cervix of postterm women not responding to prostaglandin priming. Reprod Biol Endocrinol 6:36PubMedPubMedCentralCrossRef
67.
Gordon-Wright AP, Elder MG (1980) Effect of prostaglandin E2 and its metabolites on lower segment myometrium in vitro. Eur J Obstet Gynecol Reprod Biol 10(5):297–302PubMedCrossRef
68.
Popat A, Crankshaw DJ (2001) Variable responses to prostaglandin E2 in human non-pregnant myometrium. Eur J Pharmacol 416(1–2):145–152PubMedCrossRef
69.
Chiossi G, Costantine MM, Bytautiene E, Betancourt A, Hankins GD, Saade GR, Longo M (2012) In vitro myometrial contractility profiles of different pharmacological agents used for induction of labor. Am J Perinatol 29(9):699–704PubMedCentralCrossRef
70.
Mesiano S, Wang Y, Norwitz ER (2011) Progesterone receptors in the human pregnancy uterus: do they hold the key to birth timing? Reprod Sci 18(1):6–19PubMedCrossRef
71.
Mesiano S, Chan EC, Fitter JT, Kwek K, Yeo G, Smith R (2002) Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J Clin Endocrinol Metab 87(6):2924–2930PubMedCrossRef
72.
Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O’Malley BW, McDonnell DP (1993) Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol 7(10):1244–1255PubMed
73.
Jacobsen BM, Schittone SA, Richer JK, Horwitz KB (2005) Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology. Mol Endocrinol 19(3):574–587PubMedCrossRef
74.
Klein-Hitpass L, Tsai SY, Weigel NL, Allan GF, Riley D, Rodriguez R, Schrader WT, Tsai MJ, O’Malley BW (1990) The progesterone receptor stimulates cell-free transcription by enhancing the formation of a stable preinitiation complex. Cell 60(2):247–257PubMedCrossRef
75.
Patel B, Elguero S, Thakore S, Dahoud W, Bedaiwy M, Mesiano S (2015) Role of nuclear progesterone receptor isoforms in uterine pathophysiology. Hum Reprod Update 21(2):155–173PubMedCrossRef
76.
Madsen G, Zakar T, Ku CY, Sanborn BM, Smith R, Mesiano S (2004) Prostaglandins differentially modulate progesterone receptor-A and -B expression in human myometrial cells: evidence for prostaglandin-induced functional progesterone withdrawal. J Clin Endocrinol Metab 89(2):1010–1013PubMedCrossRef
77.
Andersson S, Minjarez D, Yost NP, Word RA (2008) Estrogen and progesterone metabolism in the cervix during pregnancy and parturition. J Clin Endocrinol Metab 93(6):2366–2374PubMedPubMedCentralCrossRef
78.
Mahendroo MS, Porter A, Russell DW, Word RA (1999) The parturition defect in steroid 5α-reductase type 1 knockout mice is due to impaired cervical ripening. Mol Endocrinol 13(6):981–992PubMed
79.
Roberson AE, Hyatt K, Kenkel C, Hanson K, Myers DA (2012) Interleukin 1β regulates progesterone metabolism in human cervical fibroblasts. Reprod Sci 19(3):271–281PubMedCrossRef
80.
Kishore AH, Owens D, Word RA (2014) Prostaglandin E2 regulates its own inactivating enzyme, 15-PGDH, by EP2 receptor-mediated cervical cell-specific mechanisms. J Clin Endocrinol Metab 99(3):1006–1018PubMedPubMedCentralCrossRef
81.
Vladic-Stjernholm Y, Vladic T, Blesson CS, Ekman-Ordeberg G, Sahlin L (2009) Prostaglandin treatment is associated with a withdrawal of progesterone and androgen at the receptor level in the uterine cervix. Reprod Biol Endocrinol 7:116PubMedPubMedCentralCrossRef
82.
Stjernholm-Vladic Y, Stygar D, Mansson C, Masironi B, Akerberg S, Wang H, Ekman-Ordeberg G, Sahlin L (2004) Factors involved in the inflammatory events of cervical ripening in humans. Reprod Biol Endocrinol 2:74PubMedPubMedCentralCrossRef
83.
Esplin MS, Romero R, Chaiworapongsa T, Kim YM, Edwin S, Gomez R, Gonzalez R, Adashi EY (2003) Amniotic fluid levels of immunoreactive monocyte chemotactic protein-1 increase during term parturition. J Matern Fetal Neonatal Med 14(1):51–56PubMedCrossRef
84.
Hansen WR, Keelan JA, Skinner SJ, Mitchell MD (1999) Key enzymes of prostaglandin biosynthesis and metabolism. Coordinate regulation of expression by cytokines in gestational tissues: a review. Prostaglandins Other Lipid Mediat 57(4):243–257PubMedCrossRef
85.
Mitchell MD, Dudley DJ, Edwin SS, Schiller SL (1991) Interleukin-6 stimulates prostaglandin production by human amnion and decidual cells. Eur J Pharmacol 192(1):189–191PubMedCrossRef
86.
Ito A, Sato T, Iga T, Mori Y (1990) Tumor necrosis factor bifunctionally regulates matrix metalloproteinases and tissue inhibitor of metalloproteinases (TIMP) production by human fibroblasts. FEBS Lett 269(1):93–95PubMedCrossRef
87.
Sato T, Ito A, Mori Y (1990) Interleukin 6 enhances the production of tissue inhibitor of metalloproteinases (TIMP) but not that of matrix metalloproteinases by human fibroblasts. Biochem Biophys Res Commun 170(2):824–829PubMedCrossRef
88.
Schmitz T, Levine BA, Nathanielsz PW (2006) Localization and steroid regulation of prostaglandin E2 receptor protein expression in ovine cervix. Reproduction 131(4):743–750PubMedCrossRef
89.
Phillips RJ, Fortier MA, Lopez BA (2014) Prostaglandin pathway gene expression in human placenta, amnion and choriodecidua is differentially affected by preterm and term labour and by uterine inflammation. BMC Pregnancy Childbirth 14:241PubMedPubMedCentralCrossRef
90.
Christiaens I, Zaragoza DB, Guilbert L, Robertson SA, Mitchell BF, Olson DM (2008) Inflammatory processes in preterm and term parturition. J Reprod Immunol 79(1):50–57PubMedCrossRef
91.
Denison FC, Kelly RW, Calder AA, Riley SC (1998) Cytokine secretion by human fetal membranes, decidua and placenta at term. Hum Reprod 13(12):3560–3565PubMedCrossRef
92.
Erkinheimo TL, Saukkonen K, Narko K, Jalkanen J, Ylikorkala O, Ristimaki A (2000) Expression of cyclooxygenase-2 and prostanoid receptors by human myometrium. J Clin Endocrinol Metab 85(9):3468–3475PubMed
93.
Silverstein FE (1998) Improving the gastrointestinal safety of NSAIDs: the development of misoprostol—from hypothesis to clinical practice. Dig Dis Sci 43(3):447–458PubMedCrossRef
94.
Hawkins JS, Wing DA (2012) Current pharmacotherapy options for labor induction. Expert Opin Pharmacother 13(14):2005–2014PubMedCrossRef
95.
Pfizer (2013) Prepidil® [prescribing information]. Pfizer, New York
96.
Yount SM, Lassiter N (2013) The pharmacology of prostaglandins for induction of labor. J Midwifery Womens Health 58(2):133–144PubMedCrossRef
97.
Pfizer (2016) Cytotec® misoprostol tablets [prescribing information]. Pfizer, New York
98.
Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD (1997) Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 90(1):88–92PubMedCrossRef
99.
Powers BL, Wing DA, Carr D, Ewert K, Di SM (2008) Pharmacokinetic profiles of controlled-release hydrogel polymer vaginal inserts containing misoprostol. J Clin Pharmacol 48(1):26–34PubMedCrossRef
100.
Wing DA, Sheibani L (2015) Pharmacotherapy options for labor induction. Expert Opin Pharmacother 16(11):1657–1668PubMedCrossRef
101.
Rayburn WF (1989) Prostaglandin E2 gel for cervical ripening and induction of labor: a critical analysis. Am J Obstet Gynecol 160(3):529–534PubMedCrossRef
102.
Thomas J, Fairclough A, Kavanagh J, Kelly AJ (2014) Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database Syst Rev 6:CD003101
103.
Alfirevic Z, Aflaifel N, Weeks A (2014) Oral misoprostol for induction of labour. Cochrane Database Syst Rev 6:CD001338
104.
Chen W, Xue J, Peprah MK, Wen SW, Walker M, Gao Y, Tang Y (2016) A systematic review and network meta-analysis comparing the use of Foley catheters, misoprostol, and dinoprostone for cervical ripening in the induction of labour. BJOG 123(3):346–354PubMedCrossRef
105.
Wing DA, Jones MM, Rahall A, Goodwin TM, Paul RH (1995) A comparison of misoprostol and prostaglandin E2 gel for preinduction cervical ripening and labor induction. Am J Obstet Gynecol 172(6):1804–1810PubMedCrossRef
106.
Hofmeyr GJ, Gülmezoglu AM, Pileggi C (2010) Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev 10:CD000941
107.
Crane JM, Butler B, Young DC, Hannah ME (2006) Misoprostol compared with prostaglandin E2 for labour induction in women at term with intact membranes and unfavourable cervix: a systematic review. BJOG 113(12):1366–1376PubMedCrossRef
108.
Aghideh FK, Mullin PM, Ingles S, Ouzounian JG, Opper N, Wilson ML, Miller DA, Lee RH (2014) A comparison of obstetrical outcomes with labor induction agents used at term. J Matern Fetal Neonatal Med 27(6):592–596PubMedCrossRef
109.
Stewart RD, Bleich AT, Lo JY, Alexander JM, McIntire DD, Leveno KJ (2012) Defining uterine tachysystole: how much is too much? Am J Obstet Gynecol 207(4):290–296PubMedCrossRef
110.
Goetzl L (2014) Methods of cervical ripening and labor induction: pharmacologic. Clin Obstet Gynecol 57(2):377–390PubMedCrossRef
111.
Alfirevic Z, Keeney E, Dowswell T, Welton NJ, Dias S, Jones LV, Navaratnam K, Caldwell DM (2015) Labour induction with prostaglandins: a systematic review and network meta-analysis. BMJ 350:h217PubMedPubMedCentralCrossRef
112.
Ramsey PS, Meyer L, Walkes BA, Harris D, Ogburn PL Jr, Heise RH, Ramin KD (2005) Cardiotocographic abnormalities associated with dinoprostone and misoprostol cervical ripening. Obstet Gynecol 105(1):85–90PubMedCrossRef
113.
McMaster K, Sanchez-Ramos L, Kaunitz AM (2015) Balancing the efficacy and safety of misoprostol: a meta-analysis comparing 25 versus 50 micrograms of intravaginal misoprostol for the induction of labour. BJOG 122(4):468–476PubMedCrossRef
114.
ACOG Committee on Practice Bulletins—Obstetrics (2009) ACOG Practice Bulletin No. 107: induction of labor. Obstet Gynecol 114(2 Pt 1):386–397
115.
Ophir E, Odeh M, Hirsch Y, Bornstein J (2012) Uterine rupture during trial of labor: controversy of induction’s methods. Obstet Gynecol Surv 67(11):734–745PubMedCrossRef
116.
Andrikopoulou M, Lavery JA, Ananth CV, Vintzileos AM (2016) Cervical ripening agents in the second trimester of pregnancy in women with a scarred uterus: a systematic review and metaanalysis of observational studies. Am J Obstet Gynecol 215(2):177–194PubMedCrossRef
117.
Morrison SF, Nakamura K (2011) Central neural pathways for thermoregulation. Front Biosci 16:74–104CrossRef
118.
Robert A (1984) Prostaglandins: effects on the gastrointestinal tract. Clin Physiol Biochem 2(2–3):61–69PubMed
119.
Nasrallah R, Hassouneh R, Hebert RL (2014) Chronic kidney disease: targeting prostaglandin E2 receptors. Am J Physiol Renal Physiol 307(3):F243–F250PubMedCrossRef
120.
Keelan JA, Blumenstein M, Helliwell RJ, Sato TA, Marvin KW, Mitchell MD (2003) Cytokines, prostaglandins and parturition—a review. Placenta 24(Suppl A):S33–S46PubMedCrossRef
Metadaten
Titel
The role of prostaglandins E1 and E2, dinoprostone, and misoprostol in cervical ripening and the induction of labor: a mechanistic approach
verfasst von
Ronan Bakker
Stephanie Pierce
Dean Myers
Publikationsdatum
05.06.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 2/2017
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-017-4418-5

Weitere Artikel der Ausgabe 2/2017

Archives of Gynecology and Obstetrics 2/2017 Zur Ausgabe

Gynecologic Endocrinology and Reproductive Medicine

Comparison of three treatment strategies for cesarean scar pregnancy

Gynecologic Oncology

Expression of CD44 variant 6 and its prognostic value in benign and malignant endometrial tissue

Maternal-Fetal Medicine

Congenital cytomegalovirus infection in Central Germany: an underestimated risk

Gynecologic Endocrinology and Reproductive Medicine

Metabolic and androgen profile in underweight women with polycystic ovary syndrome

General Gynecology

Comparison of the effect of honey and mefenamic acid on the severity of pain in women with primary dysmenorrhea

General Gynecology

Promotor analysis of ESR1 in endometrial cancer cell lines, endometrial and endometriotic tissue

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

23.04.2024 Medikamente in Schwangerschaft und Stillzeit Nachrichten

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise